logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Pathology

    FiltersReset Filters
    24 results

    • aciphex

      (rabeprazole sodium)
      Waylis Therapeutics LLC
      Usage: ACIPHEX is indicated for the short-term treatment of erosive or ulcerative GERD in adults, maintenance of healing, symptomatic relief of GERD, healing of duodenal ulcers, eradication of H. pylori, treatment of pathological hypersecretory conditions, and symptomatic GERD in adolescents aged 12 and older for up to 8 weeks.

    • cimetidine

      (cimetidine)
      Bionpharma Inc.
      Usage: Cimetidine tablets are indicated for the short-term treatment of active duodenal and benign gastric ulcers, maintenance therapy for healed duodenal ulcers, erosive gastroesophageal reflux (GERD), and pathological hypersecretory conditions like Zollinger-Ellison Syndrome. Treatment durations typically do not exceed 8 to 12 weeks.

    • esomeprazole magnesium

      (Esomeprazole Magnesium)
      Torrent Pharmaceuticals Limited
      Usage: Esomeprazole magnesium for delayed-release oral suspension is indicated for healing erosive esophagitis, treating symptomatic GERD, reducing NSAID-associated gastric ulcer risk, H. pylori eradication, and long-term treatment of pathological hypersecretory conditions like Zollinger-Ellison syndrome in adults and pediatric patients.

    • famotidine

      (FAMOTIDINE)
      Ascend Laboratories, LLC
      Usage: Famotidine tablets are indicated for treating active duodenal and gastric ulcers, symptomatic nonerosive gastroesophageal reflux disease (GERD), erosive esophagitis due to GERD, and pathological hypersecretory conditions in adults. They also help reduce the risk of duodenal ulcer recurrence in adults and pediatric patients 40 kg and greater.

    • famotidine

      (Famotidine)
      Upsher-Smith Laboratories, LLC
      Usage: Famotidine for oral suspension is indicated for adults to treat active duodenal and gastric ulcers, symptomatic GERD, erosive esophagitis, hypersecretory conditions, and to reduce duodenal ulcer recurrence. In pediatric patients, it treats peptic ulcer disease and GERD, including infants under one year.

    • famotidine

      (famotidine)
      Zydus Pharmaceuticals USA Inc.
      Usage: Famotidine for oral suspension is indicated for treating active duodenal and gastric ulcers, GERD (including esophagitis), and pathological hypersecretory conditions in adults. In pediatric patients, it treats peptic ulcer disease and GERD, while infants can be treated for GERD.

    • famotidine

      (Famotidine)
      Dr. Reddy's Laboratories Inc.
      Usage: Famotidine for oral suspension is indicated for adults to treat active duodenal and gastric ulcers, GERD (symptomatic and erosive), pathological hypersecretory conditions, and to reduce duodenal ulcer recurrence. In pediatric patients, it's used for peptic ulcer disease and GERD; infants can be treated for GERD.

    • famotidine

      (Famotidine)
      Alembic Pharmaceuticals Limited
      Usage: Famotidine is indicated for the short-term treatment of active duodenal ulcers, benign gastric ulcers, and gastroesophageal reflux disease (GERD), as well as for maintenance therapy after ulcer healing. It is also used for treating pathological hypersecretory conditions like Zollinger-Ellison Syndrome.

    • famotidine

      (Famotidine)
      XLCare Pharmaceuticals, Inc.
      Usage: Famotidine tablets are indicated for treating active duodenal and gastric ulcers, symptomatic nonerosive GERD, erosive esophagitis due to GERD, and pathological hypersecretory conditions in adults. They also reduce the risk of duodenal ulcer recurrence in adults and patients weighing 40 kg or more.

    • famotidine

      (Famotidine)
      Akorn
      Usage: Famotidine for oral suspension is indicated for treating active duodenal and gastric ulcers, symptomatic GERD, erosive esophagitis due to GERD, pathologic hypersecretory conditions, and reducing duodenal ulcer recurrence in adults. In pediatric patients, it treats peptic ulcer disease and GERD, including infants under 1 year.